LGND Competitors - Ligand Pharmaceuticals Incorporated logo

LGND Competitors

Ligand Pharmaceuticals Incorporated

$286.85
-$0.09(-0.03%)
58
Overall
55
Value
50
Tech
71
Quality
How is this score calculated?
Market Cap
$5.74B
Volume
259.79K
52W Range
$175.89 - $326.63
Target Price
$351.75

LGND competitors: AMGN, SPPI, GSK, MRK, PFE. Ligand Pharmaceuticals Incorporated is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.

LGND Competitors Compared

CompanyPriceMarket capEPS est. (current yr)Dividend yieldMarketXLS Rank
AMGN Amgen Inc.$435.64$237.36B$23.551.74%65
GSK GSK plc$47.76$96.71B$4.783.87%15
MRK Merck & Co., Inc.$133.72$327.41B$2.792.54%64
PFE Pfizer Inc.$27.40$156.97B$3.056.28%62
ABCD
1SymbolPriceChangeVol
2LGND$286.85-0.0%259.79K
3
4
5
6

Get Ligand Pharmaceuticals Incorporated Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.